NEW YORK (360Dx) – Laboratory Corporation of America and Mount Sinai Health System said today that they are working together to establish the Mount Sinai Digital and Artificial Intelligence-Enabled Pathology Center of Excellence.
As part of the effort, Mount Sinai, headquartered in New York, will implement Philips' IntelliSite Pathology Solution systemwide, expanding the hospital's digital pathology capabilities.
Burlington, North Carolina-based LabCorp has placed the Philips system in four of its laboratories with plans to introduce it to additional facilities and said in a statement that it would use its experience in this area to "lead the integration of digital pathology into clinical practice across Mount Sinai's hospitals."
The Center of Excellence will be housed within Mount Sinai's Department of Pathology, Molecular and Cell-Based Medicine and will initially use the new digital pathology tools for interpretation of genitourinary cancers, primarily prostate tumors, along with head and neck cancers. The next phase of the project calls for Mount Sinai pathologists to consult on interpretations made by LabCorp's Dianon Pathology specialty lab.
"Digital pathology gives us the unprecedented opportunity to expand our services to the community at large, and engage members of our department, considered key opinion leaders in their field, to provide expert diagnostic opinions in complex cases," Carlos Cordon-Cardo, chairman of Mount Sinai's Department of Pathology, Molecular and Cell-Based Medicine, said in a statement.
"LabCorp and Mount Sinai continue to focus on innovations to enhance the quality and lower the costs of patient care, and we're pleased to introduce digital pathology to Mount Sinai as the next phase of our collaboration," said William B. Haas, senior vice president of LabCorp Diagnostics' Northeast Division.